CHU de Bordeaux, Service d'Anesthésie-Réanimation II, Bordeaux, France.
Crit Care Med. 2012 Sep;40(9):2576-82. doi: 10.1097/CCM.0b013e318258fb4f.
Measurement of total hemoglobin, based on pulse co-oximetry, is a continuous and noninvasive method that has been principally evaluated in healthy volunteers subjected to hemodilution. We tested the hypothesis that its accuracy could adversely affect patients presenting with severe hemorrhage, which is traditionally associated with increased microvascular tone.
Observational study.
Twelve-bed mixed medico-surgical intensive care unit.
Thirty-three patients admitted to our critical care unit for gastrointestinal bleeds were included.
A spectrophotometric sensor was positioned on the patient's fingertip and connected to a pulse co-oximeter. During the first 24 hrs following admission, venous hemoglobin level was determined at the laboratory every 8 hrs and was compared with hemoglobin levels displayed on the pulse co-oximeter measurements screen and/or measured from capillary blood using a portable photometer.
The primary end point was the percentage of inaccurate measurements, which were defined as >15% difference compared with reference values or their unavailability for any technical reason. Twenty-five (19%) measurements of pulse co-oximeter measurements were unavailable from the screen. Pulse co-oximeter measurements and capillary hemoglobin levels were significantly correlated to venous hemoglobin level. For venous hemoglobin level compared with pulse co-oximeter measurements (n = 105), and for venous hemoglobin level compared with capillary hemoglobin levels (n = 111), the biases were, respectively, 1.0 ± 1.9 g dL and 0.4 ± 1.0 g dL (p < .05). The proportion of inaccurate measurements was significantly higher for pulse co-oximeter measurements (56% vs. 15%, p < .05). Although the use of norepinephrine did not affect concordance parameters, unavailability of measurements was frequently observed (42% vs. 15%, p < .05).
Determination of pulse co-oximetry-based hemoglobin in patients presenting with severe gastrointestinal bleeds can be inaccurate, which renders its use to guide transfusion decisions potentially hazardous. The unavailability of measurements, especially during vasopressor infusion, represents another serious limitation for hemorrhagic patients.
基于脉搏血氧饱和度测量的总血红蛋白是一种连续的、非侵入性的方法,主要在接受血液稀释的健康志愿者中进行评估。我们检验了一个假设,即其准确性可能会对出现严重出血的患者产生不利影响,因为严重出血通常与微血管张力增加有关。
观察性研究。
十二张病床的内科-外科混合重症监护病房。
33 名因胃肠道出血而入住我们重症监护病房的患者入选。
将分光光度传感器放置在患者指尖上,并连接到脉搏血氧饱和度仪上。在入院后的头 24 小时内,每 8 小时在实验室测定静脉血红蛋白水平,并将其与脉搏血氧饱和度仪测量屏幕上显示的血红蛋白水平进行比较和/或使用便携式光度计从毛细血管血中测量。
主要终点是不准确测量的百分比,定义为与参考值相差>15%或因任何技术原因无法获得。有 25 次(19%)脉搏血氧饱和度仪的测量结果无法从屏幕上获得。脉搏血氧饱和度仪测量值和毛细血管血红蛋白水平与静脉血红蛋白水平显著相关。与静脉血红蛋白水平相比,脉搏血氧饱和度仪测量值(n = 105)和与毛细血管血红蛋白水平相比(n = 111)的偏倚分别为 1.0 ± 1.9 g/dL 和 0.4 ± 1.0 g/dL(p<.05)。脉搏血氧饱和度仪测量值的不准确测量比例显著更高(56% vs. 15%,p<.05)。虽然去甲肾上腺素的使用并未影响一致性参数,但测量结果经常无法获得(42% vs. 15%,p<.05)。
在出现严重胃肠道出血的患者中,基于脉搏血氧饱和度的血红蛋白测定可能不准确,这使其用于指导输血决策可能存在潜在危险。测量结果无法获得,特别是在血管加压素输注期间,这对出血患者来说是另一个严重的限制。